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a b s t r a c t
Synthetic attenuated virus engineering (SAVE) is an emerging technology that enables rapid attenuation
of viruses. In this study, by using SAVE we demonstrated rapid attenuation of an arterivirus, porcine
reproductive and respiratory syndrome virus (PRRSV). The major envelope GP5 gene of PRRSV was
codon-pair deoptimized aided by a computer algorithm. The codon-pair deoptimized virus, designated as
SAVE5 with a deoptimized GP5 gene, was successfully rescued in vitro. The SAVE5 virus replicated at a
lower level in vitro with a signiﬁcant decrease of GP5 protein expression compared to the wild-type
PRRSV VR2385 virus. Pigs experimentally infected with the SAVE5 virus had signiﬁcantly lower viremia
level up to 14 days post-infection as well as signiﬁcantly reduced gross and histological lung lesions
when compared to wild-type PRRSV VR2385 virus-infected pigs, indicating the attenuation of the SAVE5
virus. This study proved the feasibility of rapidly attenuating PRRSV by SAVE.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is arguably
the most economically-important swine disease facing the global
swine industry today causing devastating economic losses of approxi-
mately $664 million per year in the United States alone (Lunney et al.,
2010; Neumann et al., 2005; Nieuwenhuis et al., 2012). PRRS is caused
by an enveloped, single-stranded, positive-sense RNAvirus, PRRS virus
(PRRSV) (Benﬁeld et al., 1992; Cavanagh, 1997; de Groot et al., 2012).
The genome of PRRSV is approximately 15 kb in size and consists of
structural genes (ORF2-ORF7) and non-structural genes (ORF1a and
ORF1b) (Allende et al., 1999; Meulenberg et al., 1993; Nelsen et al.,
1999). PRRSV is extremely heterogenic with at least 9 distinct sub-
types among the type 2 PRRSV and at least 4 distinct subtypes of type
1 PRRSV (Shi et al., 2010; Stadejek et al., 2013). The current available
vaccines, although effective against homologous or closely-related
PRRSV strains, are not very effective against heterologous PRRSV
strains circulating in the swine population.
Extensive genetic variation and recombination led to frequent
emergence of new and more virulent strains of PRRSV worldwide
(Murtaugh et al., 2010; Shi et al., 2010; Tian et al., 2007). Therefore,
rapid attenuation of emerging variant ﬁeld strains of PRRSV for
further development of effective vaccines is urgently needed.
Traditional methods for attenuating PRRSV and other viruses are
usually time-consuming, and have the additional disadvantage
that the traditionally attenuated PRRSVs have an inherent risk of
reversion to a pathogenic phenotype (Meng, 2000). To overcome
these problems associated with traditional virus attenuation, in
this study we utilized a computer-based codon-pairs deoptimiza-
tion technology, synthetic attenuated virus engineering (SAVE), for
rapid attenuation of PRRSV.
It is known that, among the synonymous codon pairs encoding
the same amino acid residues, some codon pairs occur more
frequently than others in certain species (Fedorov et al., 2002;
Gutman and Hatﬁeld, 1989; Moura et al., 2007), which is known as
codon-pair bias. Different species have different codon-pair biases,
and it has been demonstrated that the codon-pair bias is related to
the efﬁciency of the protein synthesis thereby affecting the
accumulation of synthesized proteins inside cell (Coleman et al.,
2008; Mueller et al., 2010). Therefore, the principle of the SAVE
technology is that codon-pair deoptimization of a key viral gene
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decreases the protein expression levels of the corresponding gene
that are related to viral virulence. The codon-pair deoptimization
is based on computer-aided modiﬁcation of the naturally opti-
mized pairs of codons in a viral gene sequence without altering the
codon bias and the amino acid sequence (Mueller et al., 2010).
The SAVE technology was ﬁrst applied to attenuate poliovirus
(Coleman et al., 2008) by using a computer algorithm to rearrange
codons existing in a poliovirus gene fragment to change the
pattern of codon pairs but preserve codon bias or amino acids. It
was shown that the efﬁciency of polio viral protein translation was
decreased by codon-pair deoptimization, which led to poliovirus
attenuation. The SAVE approach was also applied to successfully
attenuate inﬂuenza virus (Mueller et al., 2010). Unfortunately, the
promising potential of this novel approach to rapidly attenuate
other important viruses especially veterinary viruses has not been
explored further.
The ORF5 gene of PRRSV encodes the major envelope glyco-
protein GP5, which is critical to form viral particles with the M
protein, encoded by the ORF6 (Wissink et al., 2005). The GP5
protein forms a heterodimer with the M protein which is impor-
tant for viral assembly (Van Breedam et al., 2010). This GP5-M
dimer is involved in virus entry particularly in the alveolar
macrophages, the host cells in pigs (Delputte et al., 2007). In
addition, the GP5 is associated with apoptosis induced by PRRSV in
MARC-145 cells (Gagnon et al., 2003; Miller and Fox, 2004). It has
also been demonstrated that the GP5 contains the major virulence
determinants of PRRSV (Kwon et al., 2008). The GP5 contains a
N-terminal signal peptide which overlaps with a small structural
protein encoded by ORF5a and may play a role in viral replication
(Johnson et al., 2011).
In this study, we utilized the computer-aided codon-pair
deoptimization approach to successfully attenuate PRRSV. We
demonstrated that, by deoptimization of the codon-pairs of the
major envelope GP5 gene, the modiﬁed PRRSV with a codon-pair
deoptimized GP5 gene was successfully rescued. The growth
capacity and virulence of the modiﬁed virus was compared with
the wt PRRSV both in vitro and in vivo.
Results
Characteristics of codon-pair deoptimized PRRSV GP5 gene
The distribution of the CPB score calculated from the available
swine genes (ftp://ftp.ensembl.org/pub/release-66/fasta/sus_scrofa/
cdna/) is similar to that of human genes, which is in the range of
0–0.1 (data not shown). The CPB scores of PRRSV GP5 gene was
calculated and the original CPB score for the gene was in the range
from 0.1 to 0.1. A computer algorithm was used to switch the
existing codons in the GP5 gene to more underrepresented codon-
pairs in order to decrease the CPB score of the GP5 gene to
approximate 0.3. The characteristic of the codon-pair deoptimized
GP5 gene segment is shown in Table 2. The alignment of the GP5
gene sequences between the wt VR2385 virus and the codon-pair
deoptimized SAVE5 virus is shown in Fig. 1.
Codon-pair deoptimized virus SAVE5 was successfully rescued from
recombinant infectious clone in vitro:
The recombinant DNA-launched PRRSV infectious clone with
codon-pair deoptimized GP5 gene was designated as pIR-VR2385-
SAVE5. The SAVE5 virus with codon-pair deoptimized GP5 gene
was successfully rescued from the infectious clone pIR-VR2385-
SAVE5. The infectivity of the recused SAVE5 virus was conﬁrmed
by IFA with an anti-PRRSV N monoclonal antibody in the infected
MARC-145 cells (Fig. 2).
Codon-pair deoptimization of GP5 gene reduces the corresponding
viral protein synthesis in the rescued viruses
To investigate if the codon-pair deoptimization of the GP5
affected the translation of the corresponding gene, western blot
analyses were performed to assess the viral protein expression
levels in vitro. The results showed that, at 24 hpi, the expression
levels of codon-pair deoptimized GP5 from SAVE5 virus-infected
cells were signiﬁcantly reduced when compared to wt VR2385
virus-infected cells. However, the expression levels of the viral
nucleocapsid protein N or internal control GAPDH in cells infected
with the codon-pair deoptimized SAVE5 virus was not signiﬁcantly
different from that of wt virus-infected cells (data not shown).
Codon-pair deoptimization of GP5 gene decreased the growth kinetics
of PRRSV in vitro
To compare the growth characteristics between the codon-pair
deoptimized virus (SAVE5) and the wt VR2385 virus, the growth
kinetics of the two viruses were analyzed by infecting PK15-CD163
cells as well as PAM cells with each virus at the same m.o.i. of 0.1.
Table 1
Oligonucleotide primers used in this study.
Primer ID Primer sequence (5'43') nt Position in wt
PRRSV VR2385
genome
For codon-pair deoptimized GP5 gene
CpD5F ATGTTGGGGAAATGCTTGACCG 13354–13375
CpD5R CTAAGGACGACCCCATTGTTCCG 13934–13956
For fusion PCR with codon-pair deoptimized GP5 gene
fu5F GGCAATTTTTCTTTCGAACTCAC 12382–12404
fu5R CGGTCAAGCATTTCCCCAACAT 13354–13375
5fuF CGGAACAATGGGGTCGTCCTTAG 13934–13956
5fuR AAACCCTCTAGAATAAGAGACAATGTGAGTC Vector
For real-time PCR
RTspR51 GCCCTAATTGAATAGGTGAC 14909–14928
realtime2F TTAAATATGCCAAATAACAACGG 14449–14471
realtime2R TGCCTCTGGACTGGTT 14554–14569
Table 2
Characteristics of codon-pair deoptimized PRRSV GP5 gene sequence.
Deoptimized gene
(length in bp)
Deoptimized coding
region of gene
(nt position)
Number of silent
mutations introduced
CPBa of original
gene fragment
CPB of deoptimized
gene fragment
MFEb of original gene
fragment (kcal/mol)
MFE of deoptimized gene
fragment (kcal/mol)
gp5 (603) 148–546 78 0.049 0.354 134.8 122.6
a CPB: Codon pair bias.
b MFE: Minimum free energy.
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The results showed that, in PK15-CD163 cells, the SAVE5 virus had
lower infectious titers and reduced levels of replication at all time
points with statistically signiﬁcant differences observed after 36 hpi
(Fig. 3A). Similarly, in PAM cells, the codon-pair deoptimized SAVE5
virus showed signiﬁcantly lower infectious titers at all time points
when compared with the wt VR2385 virus (Fig. 3B).
Fig. 1. An alignment of the GP5 nucleotide sequences between the wild-type (wt) VR2385 virus and the codon-pair deoptimized SAVE5 virus. The GP5 sequence of the wt
virus VR2385 was shown on top. Only differences were indicated for the SAVE5 virus.
Fig. 2. Rescue and passage of GP5 gene codon-pair deoptimized virus by synthetic attenuated virus engineering (SAVE). (A) 48 hpi, Immunoﬂuorescence assay (IFA)
conﬁrmation of the rescue of the wt PRRSV VR2385 from MARC-145 cells infected with the suspension of cells transfected with a DNA-launched wt PRRSV infectious clone
pIR-VR2385-CA. (B) There was no ﬂuorescent signal by IFA in mock-infected MARC-145 cells at 48 hpi. (C) IFA conﬁrmation of the rescue of the GP5 gene codon-pair
deoptimized SAVE5 virus at 48 hpi.
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Experimental infection of pigs with the codon-pair deoptimized
SAVE5 virus resulted in signiﬁcantly lower viral RNA loads and lower
infectious titers in sera and lung tissues compared to wt virus-
infection
The viral RNA loads in pig sera were quantiﬁed by qPCR.
The group of pigs infected with the codon-pair deoptimized SAVE5
virus had signiﬁcantly decreased viral RNA loads in sera at 7 dpi
and 14 dpi when compared to the group of pigs infected with wt
VR2385 (p¼0.032, p¼0.036) (Figs. 4A and B). The viral infectious
titers in sera were also measured and, similar to viral RNA loads,
there was also a signiﬁcantly lower infectious virus titer in the
SAVE5 virus-infected pigs compared to wt VR2385 virus-infected
pigs at both time points (p¼0.0097, p¼0.048) (Figs. 5A and B).
Fig. 3. In vitro growth kinetics of the GP5 gene codon-pair deoptimized SAVE5 virus. (A) Growth kinetics of wt virus, VR2385, and the codon-pair deoptimized virus SAVE5 in
PK15-CD163 cells. The PK15-CD163 cells were infected with each of the SAVE5 or wt VR2385 viruses at the same m.o.i of 0.1, and mock-infected cells were also included in
the experiment as a control. The viruses from the infected cells were harvested every 12 h until 72 h post-infection. The virus titers (TCID50/ml) were determined at the
indicated time points post-infection. (B) Growth kinetics of the VR2385 wt virus and the SAVE5 virus in PAM cells. The growth kinetics of the SAVE5 and wt VR2385 viruses
in PAM cells were determined similarly as described above for the PK15-CD163 cells. The symbol “n” indicates a statistically signiﬁcant difference between SAVE5 virus and
the wt VR2385 virus at that time point. The standard error bars are indicated.
Fig. 4. PRRSV RNA loads in serum samples and lung tissues from pigs experimentally infected with codon-pair deoptimized SAVE5 virus or with wt VR2385 virus. (A) PRRSV
RNA loads in serum samples at 7 dpi from the pigs (n¼8) inoculated with SAVE5, VR2385 or media (“NEG”), respectively. There was a signiﬁcant difference (indicated with n)
in serum viral RNA loads between the GP5 codon-pair deoptimized SAVE5 virus-infected group and wt VR2385 virus-infected group. (B) PRRSV RNA loads in serum samples
at 14 dpi. There was a signiﬁcant difference (indicated with n) in serum viral RNA loads between the SAVE5 virus-infected group and wt VR2385 virus-infected group.
(C) Viral RNA loads in the lung tissues collected during necropsy at 14 dpi. A signiﬁcant difference (indicated with n) between the SAVE5 virus-infected group and the wt
VR2385 virus-infected group are observed. The standard error bars are indicated. The detection limit of the experiment is 100 viral RNA copy numbers/ml. The numbers with
circles along the x axis indicate the numbers of animals in each group that tested negative for viral RNA.
Fig. 5. Viral infectious titers in serum samples of pigs experimentally infected with the GP5 codon-pair deoptimized SAVE5 virus or wt VR2385 virus. Viral infectious titers in
serum samples of pigs were quantiﬁed as TCID50/ml. There are signiﬁcant differences at both 7 dpi and 14 dpi between the SAVE5 virus-infected group and wt VR2385 virus-
infected group (indicated with n). The standard error bars are indicated. The detection limit of the experiment is 10 TCID50/ml. The numbers with circles along the x axis
indicate the numbers of animals in each group that tested negative for viral infectious titer.
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Likewise, there were also signiﬁcantly lower viral RNA loads in the
lung tissues from the SAVE5-infected pigs compared to wt VR2385
virus-infected pigs (p¼0.047) (Fig. 4C).
Pigs infected with the codon-pair deoptimized SAVE5 virus had
signiﬁcantly reduced macroscopic and microscopic lung lesions
compared to the pigs infected with the wt VR2385 virus
Pigs inoculated with the GP5 gene deoptimized virus SAVE5 or
DMEM showed absent or only very mild macroscopic lung lesions,
whereas pigs inoculated with the wt VR2385 virus developed
pronounced macroscopic lung lesions. The control pigs inoculated
with DMEM showed no lesions. The difference of the macroscopic
lung lesions between the codon-pair deoptimized SAVE5 virus
group and wt VR2385 virus group was signiﬁcant (p¼0.0057)
(Fig. 6A). The mean scores of the microscopic lung lesions were
1.3870.42 for the SAVE5 virus-infected pigs, and 3.8870.30 for
the wt VR2385 virus-infected pigs, and 0.8770.23 for the nega-
tive control pigs. Similar to the gross lung lesions, the codon-pair
deoptimized SAVE5 virus-infected group had also a signiﬁcantly
reduced mean interstitial pneumonia score compared to the wt
VR2385 virus-infected group (p¼0.0001) (Fig. 6B).
The codon-pair deoptimized GP5 gene in the SAVE5 virus is
genetically stable in vitro and in vivo
To determine if the codon-pair deoptimized GP5 gene is stable
in vitro, the SAVE5 virus were serially passaged in PAM cells for 10
passages, and the codon-pair deoptimized GP5 gene of the SAVE5
virus harvested from each passage at 24 h post-infection was
ampliﬁed by RT-PCR and sequenced. Sequence analysis revealed
that there was no change in the sequence of the GP5 gene of
SAVE5 virus after 10 serial passages, indicating that the codon-pair
deoptimized GP5 gene was genetically stable during infection of
PAMs in vitro. To determine if the codon-pair deoptimized GP5
gene is stable in vivo during SAVE5 virus replication in pigs, we
ampliﬁed and sequenced the GP5 gene region of the SAVE5 virus
recovered from the infected pigs at 14 dpi. Sequence analysis
revealed that the GP5 gene sequences of the SAVE5 virus recov-
ered from the infected pigs at 14 dpi were identical to that of
the original SAVE5 virus inocula, indicating that the codon-pair
deoptimized GP5 gene was genetically stable in pigs during in vivo
virus replication.
Discussion
The frequent emergences of novel and more virulent strains of
PRRSV worldwide necessitate the need for rapid development
of vaccines to combat against these emerging variant strains of
PRRSV. The SAVE approach based on codon-pair deoptimization is
an emerging new technology that can rapidly attenuate viruses for
further development of potential candidate vaccines. Unfortu-
nately this promising technology has only been used for poliovirus
and inﬂuenza virus attenuation and has not been broadly explored
for rapid attenuation of other important viruses, especially impor-
tant veterinary viruses (Coleman et al., 2008; Mueller et al., 2010).
In this study, we successfully attenuated PRRSV, an important
veterinary pathogen, by using the SAVE approach. PRRSV major
envelope gene GP5 was selected in this study for codon-pair
deoptimization because of its critical roles in viral assembly and
virulence. After codon-pair deoptimization of the PRRSV GP5 gene
with a computer-aided algorithm, we successfully rescued a virus,
SAVE5, with codon-pair deoptimized GP5 gene. The codon-pair
deoptimized virus SAVE5 was shown to be viable in vitro.
In vitro characterization of the SAVE5 virus revealed that, as
expected, codon-pair deoptimization led to a reduced translation
of the GP5 gene in the SAVE5 virus while the production of PRRSV
N protein in the codon-pair deoptimized virus as well as the
internal control GAPDH levels in the same cells were not affected
(data not shown), indicating the speciﬁcity of the impact of codon-
pair deoptimization on viral protein translation by SAVE. In the
porcine kidney cell line PK15 expressing the PRRSV receptor
CD163, the codon-pair deoptimized SAVE5 virus replicated to
signiﬁcantly lower titers after 36 h post-infection when compared
to that of the wt VR2385 virus. Similarly, in its in vivo natural
target cells PAM, the codon-pair deoptimized SAVE5 virus showed
signiﬁcantly lower titers at all time points when compared to that
of the wt VR2385 virus, an indication of attenuation phenotype
in vitro.
To determine if the codon-pair deoptimized virus was attenu-
ated in vivo, we conducted a comparative pathogenicity study in
SPF pigs. The results demonstrated that infection of pigs with the
codon-pair deoptimized SAVE5 virus resulted in signiﬁcantly
lower viral RNA loads in sera and lung tissues when compared
to the wt VR2385 virus-infected pigs. Similarly, the codon-pair
deoptimized SAVE5 virus also produced signiﬁcantly lower infec-
tious virus titers in sera of infected pigs. Importantly, both the
macroscopic and microscopic lung lesion scores were signiﬁcantly
reduced in SAVE5 virus-infected pigs compared to those in wt
VR2385 virus-infected pigs, indicating that the SAVE5 virus is
attenuated in vivo. The mechanism of attenuation of SAVE5 virus
seems to be due to the impact of SAVE approach on the GP5
protein expression level, which correlated to the apoptosis of
infected cells thus affecting the virus pathogenicity in vivo. In
addition, the GP5 involves in the assembly of PRRSV particles,
therefore less expression of the GP5 proteins may decrease the
yield of complete assembled viral particles, which can affect the
generation of infectious viral titer thus leading to the attenuation
of the SAVE5 virus.
Fig. 6. Macroscopic and microscopic lesions of the lung tissues from pigs experimentally infected with the GP5 codon-pair deoptimized SAVE5 virus and wt VR2385 virus
during necropsy at 14 dpi. (A) Gross lesion scores of the lung tissues from the 8 pigs in each group experimentally inoculated with SAVE5 virus and VR2385 viruses,
respectively. (B) Microscopic lesion scores of the lung tissues from 8 pigs in each group experimentally inoculated with SAVE5 and VR2385 viruses, respectively. Mock-
infected pigs with cell culture media were included as negative control (“NEG”). Signiﬁcant differences are indicated as asterisks (nn, po0.01; nnn, po0.0001).
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The codon-pair deoptimized GP5 sequence in the SAVE5 virus
was genetically stable up to 10 serial passages in PAM cells in vitro
and up to 14 dpi in vivo. The large numbers of nucleotide changes
in the deoptimized GP5 gene sequence (Fig. 1) not only signiﬁ-
cantly decrease the chance of reversion to virulence phenotype of
the attenuated SAVE5 virus also but reduce the chance of homo-
logous recombination with other ﬁeld strains of PRRSV as well.
However, it is possible that mutations may still occur in other
parts of the virus genome since we did not sequence the entire
genome of the SAVE5. Compared to the traditional virus attenua-
tion approach which typically requires serial passages of a patho-
genic virus in cell cultures, the SAVE technology is much more
rapid for virus attenuation based on direct synthesis of codon-pair
deoptimized viral gene sequence.
In summary, we successfully used SAVE to rapidly attenuate
PRRSV. The SAVE5 virus with a codon-pair deoptimized GP5 gene
was successfully rescued and displayed an attenuation phenotype
both in vitro and in vivo. A unique advantage of the SAVE approach
is that it effectively attenuates PRRSV without altering the anti-
genicity of the viral protein on the virion. Therefore, the attenu-
ated SAVE5 virus should retain the same antigenicity as the wild-
type virus. The results from this study demonstrated the feasibility
of rapid attenuation of PRRSV by the SAVE approach. Whether or
not the attenuated SAVE5 could be useful for further development
into a potential candidate MLV against PRRSV requires future in-
depth immunogenicity and challenge studies, which is not the
scope of the present study aiming to assess the PRRSV attenuation
feasibility by SAVE. Nevertheless, the SAVE approach appears to
have a broad application in rapidly attenuating important viruses.
Materials and methods
Application of computer-based algorithm to deoptimize codon pairs
of PRRSV GP5
We utilized the SAVE approach (Coleman et al., 2008) to
deoptimize the PRRSV GP5 gene by minimizing their codon pair
bias. The major envelope GP5 gene was chosen because it is one of
the major virulence determinants of PRRSV. In the GP5 gene, a
region of 146 nucleotides (nt) overlapping with ORF5a and a 16-nt
region overlapping with ORF6 were excluded for codon-pair
deoptimization to avoid the alteration of unrelated proteins.
The representation of all amino acids (excluding stop codon) in
terms of nucleotide triplets is 61, which produces the numbers of
possible codon pairs as 612¼3721. The Codon Pair Score (CPS) is
deﬁned as the natural log of the ratio of the observed over the
expected number of occurrences of each codon pair over all coding
regions. Given two codons A and B, and the corresponding amino
acid X and Y, respectively, the CPS is calculated with the equation
below:
CPS¼ ln FðABÞF Að ÞFðBÞ
F Xð ÞFðYÞUFðXYÞ
 !
Subsequently, the “CPB” (Codon Pair Bias) is computed with the
equation below:
CPB¼ ∑
k
i ¼ 1
CPSi
k1
This denotes the average CPS over an entire gene.
For a given gene, and two amino acid pairs within which, if
they are the same in terms of amino acids, but utilize different
codons, we can exchange the codon within one amino acid pair
with the other, to manipulate the CPB. We used an approximation
algorithm – simulated annealing – to minimize the CPB.
To preserve the functionality of the attenuated GP5 gene, we
maintained the secondary structure of the gene while attempting
the attenuation, and this was accomplished by restricting the
difference of the free energy of the folding of the newly generated
gene sequence with the original one. We used the RNAfold soft-
ware in the Vienna RNA package (Schuster et al., 1994) to compute
the minimum free energy (MFE).
DNA synthesis and cloning
The codon-pair deoptimized GP5 gene sequence was commer-
cially synthesized de novo (Genscript). The codon-pair deopti-
mized GP5 gene fragment was ampliﬁed with a pair of primers
CpD5F/CpD5R (Table 1). For cloning purposes, the ﬂanking frag-
ments derived from the wt viral sequence containing naturally-
occurring unique restriction sites were fused to the corresponding
codon-pair deoptimized GP5 gene fragment (Table 1) and the
fusion gene fragment was subsequently cloned into the backbone
of a DNA-launched infectious clone of PRRSV, pIR-VR2385-CA, to
replace the original GP5 gene sequence. This recombinant clone
was designated as pIR-VR2385-SAVE5.
Cells and viruses
The only susceptible cell line that is readily available to
propagate PRRSV is the monkey kidney cell line MARC-145.
However, in order to accurately assess the translation efﬁciency
and replication of the codon-pair deoptimized viruses, a cell line of
porcine origin that possesses the same translation system as the
natural host animal of PRRSV is needed. Therefore, in this study,
we utilized a susceptible porcine kidney PK15 cell line stably
expressing PRRSV receptor molecule CD163, PK15-CD163, which
was recently established in our lab for PRRSV infection following a
similar protocol described previously (Calvert et al., 2007). Cells
were maintained in modiﬁed Eagle medium (MEM) (Invitrogen)
supplemented with 2–10% fetal bovine serum (FBS) (Invitrogen),
1% antibiotic/antimycotic (Fisher), 1% sodium pyruvate (Invitro-
gen), and 1X MEM non-essential amino acids solution (Invitrogen).
Hygromycin at 100 μg/ml was added to growth medium for
selection and maintenance of the PK15-CD163 cells.
Additionally, the in vivo target cells of PRRSV, porcine alveolar
macrophages (PAMs), were also used to analyze the growth
capacity of the codon-deoptimized virus in vitro. The PAMs were
obtained by a lung lavage of a piglet from a PRRSV-free university
research herd and maintained in RPMI 1640 media (Invitrogen)
supplemented with 10% FBS (Invitrogen), 1% antibiotic/antimycotic
(Fisher). BHK-21 cells and MARC-145 cells were used for PRRSV
rescue and propagation. Both cells were cultured in Dulbecco's
modiﬁed Eagle medium (DMEM) (ATCC) supplemented with
2–10% FBS and 1% penicillin/streptomycin (Fisher).
Rescue of codon-pair deoptimized PRRSV
To rescue the codon-pair deoptimized virus, recombinant clone
pIR-VR2385-SAVE5 was transfected into BHK-21 cells as described
previously (Ni et al., 2011). The transfected cells were harvested at
24 h post-transfection by freeze–thaw 3 times, and the cell lysates
were passaged onto MARC-145 cells. To conﬁrm the rescue of the
codon-pair deoptimized virus, an immunoﬂuorescence assay (IFA)
with an anti-PRRSV N antibody was performed at 48 h post-
infection (hpi) as previously described (Ni et al., 2011). After three
passages of the virus on MARC-145 cells, the genomic region
spanning the codon-pair deoptimized GP5 gene from the rescued
virus was ampliﬁed and sequenced to conﬁrm the successful
rescue of the virus and the genetic stability of the codon-pair
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deoptimized GP5 gene in vitro. The virus rescued from pIR-
VR2385-SAVE5 was designated as SAVE5.
Growth characterization of codon pair deoptimized SAVE5 virus
in vitro
To analyze the impact of codon-pair deoptimization of GP5
gene on the growth capacity of the rescued virus in vitro, a PRRSV-
susceptible porcine kidney cell line PK15-CD163 and the in vivo
natural target cells of PRRSV, PAM, were used for viral infection
and growth characterization. For PK15-CD163 cells, conﬂuent
monolayers of PK15-CD163 cells seeded in 96-well plates were
infected with the wt PRRSV VR2385 as well as with the codon-pair
deoptimized SAVE5 virus at multiplicity of infection (m.o.i.) of 0.1,
respectively. The infected cells were harvested at 6, 12, 24, 36, 48,
60 and 72 hpi, and the infectious titers of the viruses were
determined as described previously (Ni et al., 2013). Triplicate
experiments were performed in this study. Similarly, the growth
capacity of the SAVE5 was also characterized in PAM cells
essentially as described for the PK15-CD163 cells.
Western blotting analysis
To analyze the effect of codon-pair deoptimization of GP5 gene
on viral protein translation, we performed western blot analyses.
Brieﬂy, at 24 hpi, the infected PK15-CD163 cells were rinsed twice
with 4 1C phosphate-buffered saline (PBS) and lysed with RIPA
buffer. The BCA Protein Assay Kit (Pierce) was used, according to
the manufacturer's instruction, to quantify the total protein con-
centration of the lysed samples. The same amount of the total
proteins (50 μg) from each sample was loaded and separated by
SDS-polyacrylamide gel electrophoresis (PAGE) and subsequently
transferred to a nitrocellulose membrane. For Western blotting
analysis, the membrane was ﬁrst blocked with Odyssey blocking
buffer (Licor Biosciences) for 1 h, and then incubated with
polyclonal antibody speciﬁc to GP5 (Biomatik), N protein (SR30
from Rural Technologies, Inc.) or GAPDH (Thermo Scientiﬁc)
diluted in PBS with 0.05% Tween 20 (PBST) and 10% blocking
buffer at 4 1C overnight. After three washes of 10 min each with
PBST, the membrane was incubated again with either IRDye 680RD
Goat anti-Mouse IgG or IRDye 800CW Goat anti-Rabbit IgG
according to the respective primary antibody (Licor Biosciences)
diluted in 0.05% PBST with 10% blocking buffer for 1 h at room
temperature. After three washes of 10 min each with PBST, the
proteins were visualized via the Licor Odyssey imaging device
(Licor Biosciences).
Pathogenicity study of the codon-pair deoptimized SAVE5 virus in
speciﬁc-pathogen-free (SPF) pigs
To determine the virulence of the codon-pair deoptimized
SAVE5 virus, a comparative pathogenicity study was conducted
in SPF pigs. The animal study was approved by the Institutional
Animal Care and Use (IACUC) Committees from Virginia Tech and
Iowa State University. A group of 8 pigs were each intramuscularly
inoculated with 2 ml of SAVE5 virus (2105 TCID50/pig), respec-
tively. Another group of 8 pigs were each mock-infected with 2 ml
of the cell culture media as negative controls, and a third group of
8 pigs were each intramuscularly inoculated with 2 ml of the wt
VR2385 virus (2105 TCID50/pig) as positive controls. Serum
samples from each pig were collected prior to inoculation and
weekly thereafter and tested for viral loads by quantitative RT-PCR
and for infectious virus titers by a TCID50 infectivity assay in
MARC-145 cells. All pigs were euthanized at 14 dpi, and the gross
lung lesions were evaluated and scored at the time of necropsy
according to a published method (Halbur et al., 1995). Lung tissues
from each pig were also collected and ﬁxed in 10% neutral buffered
formalin and processed for histological examination of micro-
scopic lung lesions (Halbur et al., 1995).
Quantitation of viral RNA loads using SYBR-green based qRT-PCR
To quantify the viral RNA loads in serum and lung tissues from
each pig after infection with virus or DMEM, a SYBR-Green based
quantitative RT-PCR was used. Total RNAs were extracted from
serum or lung tissue samples using TRI Reagent (MRC) and reverse
transcribed to cDNA using the Superscript II kit (Invitrogen) with
primer RTspR51 (Table 1). The subsequent qPCR assay was con-
ducted in a CFX96 real-time PCR system (Bio-Rad). A pair of
primers located in the conserved regions of PRRSV N gene
(realtime2F and realtime2R, Table 1) was designed by utilizing
the Beacon software and used in the PCR reactions as described (Ni
et al., 2013). A dissociation curve analysis was performed using the
instrument's default setting immediately after each PCR run to
conﬁrm the speciﬁcity of PCR product. Reaction was performed in
triplicates.
Quantiﬁcation of infectious virus titers in serum samples of infected
pigs by an infectivity assay
To determine the infectious virus titers in serum samples, a TCID50
assay were performed as described previously (Ni et al., 2013). Brieﬂy,
10-fold serially diluted serum samples (101–104) collected at
different dpi's from pigs were used to infect MARC-145 cells seeded
in 96-well plates. After 1 h incubation at 37 1C, the inocula were
removed and the cells were washed twice with PBS. The cells were
maintained in fresh DMEMmedia supplemented with 2% fetal bovine
serum for 48 h at 37 1C before being ﬁxed with 80% acetone (Sigma).
The infectious titer of each serum sample was subsequently quantiﬁed
using an immunoﬂuorescence-based assay (Ni et al., 2013). Titration
was performed in triplicates in this study.
Evaluation of gross and histological lesions in the lungs of infected
pigs
The gross and histological lung lesions were evaluated by a
veterinary pathologist who was blind to the treatment groups of
the pigs. The scoring system for estimating the macroscopic lung
lesions was based on the approximate volume that each lung lobe
contributes to the entire lung as described previously (Halbur
et al., 1995; Ni et al., 2013). Histological lung sections representa-
tive of all lobes from each pig were scored for the presence and
severity of interstitial pneumonia ranging from 0 (normal) to 6
(severe diffuse interstitial pneumonia) as previously described
(Halbur et al., 1995; Ni et al., 2013).
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